| Particulars |
|
|
|
| Company Name
| Mankind Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
41.28 |
B.V. (₹) |
354.70 |
| Sales(₹ Cr.) |
9,497.80 |
NP (₹ Cr.) |
1,691.18 |
| NP Var% |
-4.00 |
Div% |
0.00 |
| CPS(₹) |
50.10 |
EPS (₹) |
41.00 |
| Traded Value(₹ Lakhs) |
61.81 |
52 Week High |
3,050.00 |
| 52 Week Low |
2,116.00 |
Price BSE |
2,437.00 |
| Price NSE |
2,436.00 |
Market Capital (₹ Cr.) |
100,587.18 |
| P/C Ratio |
48.60 |
P/E Ratio |
59.50 |
| Price Vs.BV |
6.87 |
|
| Latest Quarter |
| Year End |
202506 |
Sales (₹ Cr.) |
2,541.36 |
| NP(₹ Cr.) |
412.76 |
NP Var % |
-13.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
9,288.12 |
| OPM |
25.95 |
NP |
2,004.35 |
| NP Var% |
-1.13 |
EPS |
43.84 |
| PE |
55.59 |
|
|